DoW Toxic Exposures Translational Research Award
This grant funds collaborative translational research to speed up the development of clinical applications for military-related toxic exposure, supporting partnerships between clinicians and scientists.
Funder: Dept. of the Army -- USAMRAA
Due Dates (Anticipated): November 2026 (Full application deadline, projected)
Funding Amounts: Estimated total program funding: $6,000,000; ~4 awards expected; award size not specified.
Summary: Supports translational research accelerating military-related toxic exposure findings into clinical applications, with emphasis on interdisciplinary collaboration.
Key Information: Forecasted opportunity—dates and details may change; partner PI option available.
Description
This forecasted opportunity from the Dept. of the Army -- USAMRAA aims to fund translational research that advances promising concepts in military-related toxic exposure into clinical applications. The program encourages projects that bridge basic science and clinical observations, with the goal of developing health care products, interventions, technologies, or clinical practice guidelines to address toxic exposures affecting military personnel. A distinctive feature is the Partnering Principal Investigator Option (PPIO), which supports interdisciplinary collaborations (e.g., between clinicians and research scientists) to accelerate translation into clinical use. Each PI in a partnership, if funded, receives a separate award.
